We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$330M
AUM Growth
-$23.6M
Cap. Flow
-$25.7M
Cap. Flow %
-7.79%
Top 10 Hldgs %
34.6%
Holding
110
New
18
Increased
26
Reduced
40
Closed
25

Top Buys

Rank Stock Value
1
SBRA icon
Sabra Healthcare REIT
SBRA
+$12.6M
2
DHR icon
Danaher
DHR
+$11.5M
3
MD icon
Pediatrix Medical
MD
+$8.38M
4
JNJ icon
Johnson & Johnson
JNJ
+$7.49M
5
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$5.94M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$8.41M
2
UNH icon
UnitedHealth
UNH
+$6.51M
3
BCR
CR Bard Inc.
BCR
+$6.28M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$6.22M
5
TMO icon
Thermo Fisher Scientific
TMO
+$5.98M

Sector Composition

Rank Sector Weight
1 Healthcare 82.72%
2 Real Estate 3.7%
3 Financials 2.96%
4 Industrials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVA icon
1
DaVita
DVA
$15.4B
$16.3M 4.93%
274,223
+88,726
+48% +$5.34M
BIIB icon
2
Biogen
BIIB
$30B
$12.5M 3.78%
39,817
+8,185
+26% +$2.42M
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$12.3M 3.72%
731,509
-19,025
-3% -$310K
SBRA icon
4
Sabra Healthcare REIT
SBRA
$5.34B
$12.2M 3.7%
+556,330
New +$12.6M
DHR icon
5
Danaher
DHR
$137B
$11.8M 3.58%
+155,512
New +$11.5M
ABT icon
6
Abbott
ABT
$183B
$11.3M 3.43%
211,983
-38,800
-15% -$1.95M
TMO icon
7
Thermo Fisher Scientific
TMO
$213B
$11.3M 3.42%
59,608
-33,000
-36% -$5.98M
AET
8
DELISTED
Aetna Inc
AET
$9.77M 2.96%
61,427
+5,000
+9% +$781K
SHPG
9
DELISTED
Shire pic
SHPG
$8.47M 2.57%
55,296
+2,300
+4% +$360K
AGN
10
DELISTED
Allergan plc
AGN
$8.3M 2.51%
40,477
+6,950
+21% +$1.62M
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$8.2M 2.48%
201,000
+153,300
+321% +$5.94M
PFE icon
12
Pfizer
PFE
$143B
$8.12M 2.46%
239,594
-4,302
-2% -$138K
UHS icon
13
Universal Health Services
UHS
$10.2B
$7.89M 2.39%
71,100
-39,300
-36% -$4.42M
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
$7.84M 2.37%
123,790
-5,700
-4% -$354K
MD icon
15
Pediatrix Medical
MD
$2.18B
$7.61M 2.3%
+176,400
New +$8.38M
JNJ icon
16
Johnson & Johnson
JNJ
$618B
$7.35M 2.23%
+56,500
New +$7.49M
MCK icon
17
McKesson
MCK
$100B
$7.04M 2.13%
45,800
-27,203
-37% -$4.25M
ELV icon
18
Elevance Health
ELV
$81.5B
$6.23M 1.89%
32,811
-16,404
-33% -$3.12M
BSX icon
19
Boston Scientific
BSX
$69.5B
$6.14M 1.86%
210,498
+82,800
+65% +$2.29M
CAH icon
20
Cardinal Health
CAH
$53.9B
$5.79M 1.76%
86,571
-14,120
-14% -$998K
BCR
21
DELISTED
CR Bard Inc.
BCR
$5.49M 1.66%
17,139
-19,622
-53% -$6.28M
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.42M 1.64%
100,400
+81,200
+423% +$4.77M
BBH icon
23
VanEck Biotech ETF
BBH
$400M
$5.2M 1.58%
38,799
-7,200
-16% -$938K
NSTG
24
DELISTED
NanoString Technologies, Inc.
NSTG
$4.77M 1.45%
295,260
-214,400
-42% -$3.31M
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
$4.68M 1.42%
56,750
+25,100
+79% +$1.99M
1
2 3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Endurant Capital Management held 110 positions worth $330M, down 6.7% from $354M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management withdrew a net $25.7M in Q3 2017, closing 25 positions and reducing 40 holdings. Its most notable exit was K2M Group Holdings, Inc, an estimated $3.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 88% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Endurant Capital Management opened a new position in Sabra Healthcare REIT worth $12.2M.

  • Endurant Capital Management's largest Q3 2017 buy was Sabra Healthcare REIT: 556,330 shares worth $12.2M.
  • Endurant Capital Management added most to Tivity Health, Inc. Common Stock in Q3 2017, an estimated $5.94M increase.
  • Endurant Capital Management's biggest Q3 2017 reduction was Becton Dickinson, cutting an estimated $8.41M.
  • Endurant Capital Management fully exited K2M Group Holdings, Inc in Q3 2017, selling an estimated $3.4M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $330M portfolio in Q3 2017.
  • Endurant Capital Management opened 18 new positions and closed 25 in Q3 2017.
  • Endurant Capital Management's portfolio value fell 6.7% quarter-over-quarter to $330M.

Based on Endurant Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.